Correspondence re: A. Kumar et al., cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res., 61: 7552-7555, 2001.
Garattini
Enrico
E
Gianni'
Maurizio
M
Terao
Mineko
M
D000970:Antineoplastic Agents / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D017239:Paclitaxel / Q000494:pharmacology*; D018168:Receptors, Retinoic Acid / Q000096:biosynthesis*; D012176:Retinoids / Q000494:pharmacology*; D000097768:Retinoic Acid Receptor gamma
D000970:Antineoplastic Agents; D017239:Paclitaxel; D018168:Receptors, Retinoic Acid; D012176:Retinoids; D000097768:Retinoic Acid Receptor gamma; C099555:CD 437